Delivery Order SPE2DB24D2205-SPE2DB24FDWPF
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$69K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 MG TABLET for a ceiling value of $48,405.36. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous contracts by federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, to...
The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109799 RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $3,999.43 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has been awarded multiple federal contracts by DLA to provide pharmaceutical products and medical supplies in...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $25,278.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of the prescription drug RINVOQ ER 15 MG TABLET. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET in quantities of 28. The completion date for this $6,863.94 contract is January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
The U.S. Defense Logistics Agency (DLA) awarded a $6,645.44 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET medication. The contract has an ultimate completion date of October 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a $69,691.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This is a delivery order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for the provision of a comprehensive range...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,983.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564110483 RINVOQ ER 30 MG TABLET UU 30S. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...